Article Text
Statistics from Altmetric.com
Several ethicists recently defended regulations that aim to reduce the harm associated with nicotine and tobacco use. Halliday argues for smoking licences.1 van der Eijk endorses strict limits on access to electronic nicotine delivery systems (ENDS)2 and Grill and Voigt defend a complete ban on the sale of cigarettes.3 These proposals are supported by principles that are widely shared by public health officials and many philosophers. For example, Goodin,4 Conly,5 Proctor,6 Hooper and Agule7 and Wilson8 all express support for smoking bans or cigarette taxes.
It is uncontroversial that smoking is a very unhealthy practice. Smoking limits a person's life expectancy by a decade on average, causes chronic diseases and is often a choice that people come to regret.3 Smoking is the largest preventable cause of death in the world, which is why Proctor calls cigarettes a public health catastrophe.6 But it does not follow from the fact that smoking is enormously bad for people's health that prohibitive tobacco and nicotine laws are justified. Though criticism of the tobacco industry is warranted,6 I argue that policies that amount to coercive paternalism are nevertheless unacceptable and only a non-prohibitive approach to smoking cessation is justifiable.
Philosophers rely on four double standards when arguing for prohibitive antismoking policies. First, they hold addictive nicotine products to more restrictive standards than other threats to individual autonomy. Second, they hold the tobacco industry to more restrictive standards than other potentially harmful industries. Third, they hold public health officials to weaker moral standards than they would apply to other citizens. Fourth, they hold their own proposals to standards of ideal enforcement while citing the non-ideal effects of a non-prohibitive system. Many of the arguments in favour of restricting tobacco and nicotine products also overlook less …
Footnotes
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.
↵i In the EU, see Directive 2003/33/EC of the European Parliament and of the Council of 26 May 2003 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the advertising and sponsorship of tobacco products. The WHO Framework Convention on Tobacco Control is a treaty that has been ratified by 180 countries. In a later section, I note that I am in agreement with WHO's call for drug decriminalization. In both cases, I do not doubt WHO's claims about whether a policy would promote public health. But in this case, I argue that public health is not a sufficient reason for restrictions on speech.
↵ii Another notable exception is pharmaceutical advertising, which is regulated in part by the US Food and Drug Administration, which prohibits manufacturers from advertising truthful information about the off-label uses of drugs.
↵iii Grill and Voigt write, “We assume that such a ban would be effective. In the real world, of course, any all-things-considered judgment must be informed by an assessment of a ban's likely effectiveness in different contexts, with due consideration of problems such as smuggled cigarettes and black markets.” Yet Grill and Voigt are focused on ‘the fundamental normative issues’ surrounding a cigarette ban.3
↵iv This argument does not rule out a middle ground approach. One may reply that coercive paternalism could be justified by the same standards that would justify a less coercive tobacco policy. Though I have argued elsewhere that coercive public health paternalism is generally unjustified,15 my arguments in this essay do not rule out the possibility that some coercive tobacco policies could be justified as long as they were held to the same standards as other policies. In any case, such policies would not include the policies that I have discussed so far.
Linked Articles
- Mini-Symposium: Regulating smoking
- Mini-Symposium: Regulating smoking
- The concise argument
Read the full text or download the PDF:
Other content recommended for you
- New tobacco and nicotine products in Latin America and the Caribbean: assessing the market and regulatory environment
- Moving targets: how the rapidly changing tobacco and nicotine landscape creates advertising and promotion policy challenges
- Longitudinal transitions of exclusive and polytobacco electronic nicotine delivery systems (ENDS) use among youth, young adults and adults in the USA: findings from the PATH Study Waves 1–3 (2013–2016)
- Electronic nicotine delivery system (electronic cigarette) awareness, use, reactions and beliefs: a systematic review
- Trajectories of ENDS and cigarette use among dual users: analysis of waves 1 to 5 of the PATH Study
- Electronic nicotine delivery systems: the need for continued regulatory innovation
- Changing patterns of cigarette and ENDS transitions in the USA: a multistate transition analysis of youth and adults in the PATH Study in 2015–2017 vs 2017–2019
- Associations between tobacco 21 and state flavour restrictions with young adult tobacco use
- “I’m both smoking and vaping”: a longitudinal qualitative study of US young adults who tried to quit smoking cigarettes by using electronic cigarettes
- Electronic nicotine delivery system use behaviour and loss of autonomy among American Indians: results from an observational study